Advertisement
Screener

Quanterix Corporation (QTRX) Operating Cash Flow

2.8 / 5 stars · 68/120 Roast Me

Quanterix Corporation Operating Cash Flow

Quanterix Corporation (QTRX) reported Operating Cash Flow of -$23.23 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.

Financial Statements › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-10

  • Quanterix Corporation net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$5.12M.
  • Quanterix Corporation net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$18.11M.
  • Quanterix Corporation net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$16.44M.
  • Quanterix Corporation net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$41.25M.
  • Quanterix Corporation net cash provided by (used in) operating activities for fiscal 2025 was -$77.24M.
  • Quanterix Corporation net cash provided by (used in) operating activities for fiscal 2024 was -$35.16M.
  • Quanterix Corporation net cash provided by (used in) operating activities for fiscal 2023 was -$18.85M.
  • Quanterix Corporation net cash provided by (used in) operating activities for fiscal 2022 was -$48.61M.
Period endNet Cash Provided by (Used in) Operating Activities 3 monthNet Cash Provided by (Used in) Operating Activities 3 month as first filedNet Cash Provided by (Used in) Operating Activities 6 monthNet Cash Provided by (Used in) Operating Activities 6 month as first filedNet Cash Provided by (Used in) Operating Activities 9 monthNet Cash Provided by (Used in) Operating Activities 9 month as first filedNet Cash Provided by (Used in) Operating Activities 12 monthNet Cash Provided by (Used in) Operating Activities 12 month as first filed
2026-06-30-$5.12M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10
-$23.23M
10-Q · filed 2026-08-10
-$39.67M
derived: sum of 3 quarters · filed 2026-08-10
-$80.92M
derived: sum of 4 quarters · filed 2026-08-10
2026-03-31-$18.11M
10-Q · filed 2026-05-06
-$34.55M
derived: sum of 2 quarters · filed 2026-05-06
-$75.80M
derived: sum of 3 quarters · filed 2026-05-06
-$81.45M
derived: sum of 4 quarters · filed 2026-08-10
2025-12-31-$16.44M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02
-$57.69M
derived: sum of 2 quarters · filed 2026-03-02
-$63.35M
derived: sum of 3 quarters · filed 2026-08-10
-$77.24M
10-K · filed 2026-03-02
2025-09-30-$41.25M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10
-$46.90M
derived: sum of 2 quarters · filed 2026-08-10
-$60.79M
10-Q · filed 2025-11-10
-$65.09M
derived: sum of 4 quarters · filed 2026-08-10
2025-06-30-$5.66M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10
-$19.54M
10-Q · filed 2026-08-10
-$23.84M
derived: sum of 3 quarters · filed 2026-08-10
-$29.59M
derived: sum of 4 quarters · filed 2026-08-10
2025-03-31-$13.89M
10-Q · filed 2026-05-06
-$18.19M
derived: sum of 2 quarters · filed 2026-05-06
-$23.94M
derived: sum of 3 quarters · filed 2026-05-06
-$28.89M
derived: sum of 4 quarters · filed 2026-05-06
2024-12-31-$4.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02
-$10.05M
derived: sum of 2 quarters · filed 2026-03-02
-$15.00M
derived: sum of 3 quarters · filed 2026-03-02
-$35.16M
10-K · filed 2026-03-02
2024-09-30-$5.75M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10
-$10.70M
derived: sum of 2 quarters · filed 2025-11-10
-$30.86M
10-Q · filed 2025-11-10
-$37.05M
derived: sum of 4 quarters · filed 2026-03-02
2024-06-30-$4.95M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
-$25.11M
10-Q · filed 2025-08-07
-$31.31M
derived: sum of 3 quarters · filed 2026-03-02
-$35.17M
derived: sum of 4 quarters · filed 2026-03-02
2024-03-31-$20.16M
10-Q · filed 2025-05-12
-$26.36M
derived: sum of 2 quarters · filed 2026-03-02
-$30.22M
derived: sum of 3 quarters · filed 2026-03-02
-$29.19M
derived: sum of 4 quarters · filed 2026-03-02
2023-12-31-$6.19M
derived: 10-K 12 month − 10-K/A 9 month · filed 2026-03-02
-$10.06M
derived: sum of 2 quarters · filed 2026-03-02
-$9.03M
derived: sum of 3 quarters · filed 2026-03-02
-$18.85M
10-K · filed 2026-03-02
-$18.90M
10-K · filed 2024-02-29
2023-09-30-$3.87M
derived: 10-K/A 9 month − 10-K/A 6 month · filed 2024-12-26
-$2.83M
derived: sum of 2 quarters · filed 2024-12-26
-$12.66M
10-K/A · filed 2024-12-26
-$12.92M
10-Q · filed 2023-11-08
-$16.75M
derived: sum of 4 quarters · filed 2025-03-17
2023-06-30$1.03M
derived: 10-K/A 6 month − 10-K/A 3 month · filed 2024-12-26
-$8.79M
10-K/A · filed 2024-12-26
-$8.87M
10-Q · filed 2023-08-08
-$12.88M
derived: sum of 3 quarters · filed 2025-03-17
-$27.69M
derived: sum of 4 quarters · filed 2025-03-17
2023-03-31-$9.82M
10-K/A · filed 2024-12-26
-$9.50M
10-Q · filed 2023-05-09
-$13.91M
derived: sum of 2 quarters · filed 2025-03-17
-$28.72M
derived: sum of 3 quarters · filed 2025-03-17
-$36.68M
derived: sum of 4 quarters · filed 2025-03-17
2022-12-31-$4.09M
derived: 10-K 12 month − 10-K/A 9 month · filed 2025-03-17
-$18.89M
derived: sum of 2 quarters · filed 2025-03-17
-$26.86M
derived: sum of 3 quarters · filed 2025-03-17
-$48.61M
10-K · filed 2025-03-17
-$48.27M
10-K · filed 2023-03-06
2022-09-30-$14.80M
derived: 10-K/A 9 month − 10-K/A 6 month · filed 2024-12-26
-$22.77M
derived: sum of 2 quarters · filed 2024-12-26
-$44.52M
10-K/A · filed 2024-12-26
-$44.18M
10-Q · filed 2022-11-09
-$54.53M
derived: sum of 4 quarters · filed 2024-12-26
2022-06-30-$7.96M
derived: 10-K/A 6 month − 10-K/A 3 month · filed 2024-12-26
-$29.72M
10-K/A · filed 2024-12-26
-$29.64M
10-Q · filed 2022-08-08
-$39.72M
derived: sum of 3 quarters · filed 2024-12-26
-$53.50M
derived: sum of 4 quarters · filed 2024-12-26
2022-03-31-$21.75M
10-K/A · filed 2024-12-26
-$21.70M
10-Q · filed 2022-05-10
-$31.76M
derived: sum of 2 quarters · filed 2024-12-26
-$45.54M
derived: sum of 3 quarters · filed 2024-12-26
-$55.29M
derived: sum of 4 quarters · filed 2024-12-26
2021-12-31-$10.01M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-12-26
-$23.78M
derived: sum of 2 quarters · filed 2024-12-26
-$33.53M
derived: sum of 3 quarters · filed 2024-12-26
-$47.62M
10-K/A · filed 2024-12-26
-$47.91M
10-K · filed 2022-03-01
2021-09-30-$13.78M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
-$23.53M
derived: sum of 2 quarters · filed 2022-11-09
-$37.62M
10-Q · filed 2022-11-09
-$32.96M
derived: sum of 4 quarters · filed 2023-03-06
2021-06-30-$9.75M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08
-$23.84M
10-Q · filed 2022-08-08
-$19.18M
derived: sum of 3 quarters · filed 2023-03-06
-$26.60M
derived: sum of 4 quarters · filed 2023-03-06
2021-03-31-$14.09M
10-Q · filed 2022-05-10
-$9.44M
derived: sum of 2 quarters · filed 2023-03-06
-$16.85M
derived: sum of 3 quarters · filed 2023-03-06
-$24.27M
derived: sum of 4 quarters · filed 2023-03-06
2020-12-31$4.65M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06
-$2.77M
derived: sum of 2 quarters · filed 2023-03-06
-$10.19M
derived: sum of 3 quarters · filed 2023-03-06
-$23.36M
10-K · filed 2023-03-06
2020-09-30-$7.42M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04
-$14.84M
derived: sum of 2 quarters · filed 2021-11-04
-$28.02M
10-Q · filed 2021-11-04
-$32.55M
derived: sum of 4 quarters · filed 2022-03-01
2020-06-30-$7.42M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05
-$20.60M
10-Q · filed 2021-08-05
-$25.14M
derived: sum of 3 quarters · filed 2022-03-01
-$33.97M
derived: sum of 4 quarters · filed 2022-03-01
2020-03-31-$13.18M
10-Q · filed 2021-05-06
-$17.71M
derived: sum of 2 quarters · filed 2022-03-01
-$26.55M
derived: sum of 3 quarters · filed 2022-03-01
-$34.01M
derived: sum of 4 quarters · filed 2022-03-01
2019-12-31-$4.54M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
-$13.37M
derived: sum of 2 quarters · filed 2022-03-01
-$20.84M
derived: sum of 3 quarters · filed 2022-03-01
-$26.19M
10-K · filed 2022-03-01
2019-09-30-$8.83M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06
-$16.30M
derived: sum of 2 quarters · filed 2020-11-06
-$21.65M
10-Q · filed 2020-11-06
-$29.76M
derived: sum of 4 quarters · filed 2021-03-05
2019-06-30-$7.47M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04
-$12.82M
10-Q · filed 2020-08-04
-$20.93M
derived: sum of 3 quarters · filed 2021-03-05
-$27.57M
derived: sum of 4 quarters · filed 2021-03-05
2019-03-31-$5.35M
10-Q · filed 2020-05-07
-$13.46M
derived: sum of 2 quarters · filed 2021-03-05
-$20.10M
derived: sum of 3 quarters · filed 2021-03-05
-$24.01M
derived: sum of 4 quarters · filed 2021-03-05
2018-12-31-$8.11M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-05
-$14.75M
derived: sum of 2 quarters · filed 2021-03-05
-$18.66M
derived: sum of 3 quarters · filed 2021-03-05
-$28.72M
10-K · filed 2021-03-05
2018-09-30-$6.64M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08
-$10.55M
derived: sum of 2 quarters · filed 2019-11-08
-$20.61M
10-Q · filed 2019-11-08
-$25.02M
derived: sum of 4 quarters · filed 2020-03-13
2018-06-30-$3.91M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06
-$13.97M
10-Q · filed 2019-08-06
-$18.37M
derived: sum of 3 quarters · filed 2020-03-13
-$25.86M
derived: sum of 4 quarters · filed 2020-03-13
2018-03-31-$10.06M
10-Q · filed 2019-05-10
-$14.46M
derived: sum of 2 quarters · filed 2020-03-13
-$21.95M
derived: sum of 3 quarters · filed 2020-03-13
-$28.18M
derived: sum of 4 quarters · filed 2020-03-13
2017-12-31-$4.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13
-$11.89M
derived: sum of 2 quarters · filed 2020-03-13
-$18.11M
derived: sum of 3 quarters · filed 2020-03-13
-$22.11M
10-K · filed 2020-03-13
2017-09-30-$7.49M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07
-$13.71M
derived: sum of 2 quarters · filed 2018-11-07
-$17.70M
10-Q · filed 2018-11-07
2017-06-30-$6.23M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10
-$10.22M
10-Q · filed 2018-08-10
2017-03-31-$3.99M
10-Q · filed 2018-05-15
2016-12-31-$17.74M
10-K · filed 2019-03-18

Similar stocks

Stock NameCountryMarket CapPE Ratio
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Seer, Inc. (SEER)United States$0.104B-1.34
Precipio, Inc. (PRPO)United States$0.043B-36.70
HARVARD BIOSCIENCE INC (HBIO)United States$0.037B-2.70
Bionano Genomics, Inc. (BNGO)United States$0.020B-0.42
ASTROTECH Corp (ASTC)United States$0.013B
EyePoint, Inc. (EYPT)United States$0.314B-3.96
908 Devices Inc. (MASS)United States$0.476B-9.53
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15